# LEVETIRACETAM IN SODIUM CHLORIDE
> **ANDA208619** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2023-01-31
## Drug
- **FDA Application Number:** ANDA208619
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVETIRACETAM IN SODIUM CHLORIDE
- **Generic name:** LEVETIRACETAM
- **Active ingredients:** LEVETIRACETAM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Hp Halden Pharma AS
- **First approval:** 2023-01-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208619)
---
*AI Analytics · CC0 1.0*